DOI: 10.1055/s-00023610

Drug Research

References

Samukawa Y, Sata M, Furihata K. et al.
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study.

Clin Pharmacol Drug Dev 2017;
6: 439-447

Download Bibliographical Data

Access: